Market Summary
USD185.07+0.07
Market Closed0.04%
INSP Stock Price
INSP RSI Chart
INSP Valuation
INSP Price/Sales (Trailing)
INSP Profitability
INSP Fundamentals
INSP Revenue
INSP Earnings
Price Action
52 Week Range
159.62330.00
(Low)(High)
Last 7 days
-12.3%
Last 30 days
-12.4%
Last 90 days
-41.3%
Trailing 12 Months
8.4%
INSP Financial Health
INSP Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for INSP
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-14 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-09-08 | Herbert Timothy P. | sold | - | - | -47,992 | ceo and president |
2023-09-08 | Herbert Timothy P. | gifted | - | - | -47,992 | ceo and president |
2023-08-28 | Jandrich Steven | acquired | 2,350 | 0.94 | 2,500 | vp, human resources |
2023-08-24 | Herbert Timothy P. | gifted | - | - | -3,224 | ceo and president |
2023-08-23 | Herbert Timothy P. | acquired | 67,230 | 70.5459 | 953 | ceo and president |
2023-08-21 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-08-10 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-08-07 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
2023-08-04 | NELSON MARILYN C | acquired | 1,880 | 0.94 | 2,000 | - |
Which funds bought or sold INSP recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | 4,067 | 14,578 | -% |
2023-09-20 | BARCLAYS PLC | added | 33.78 | 5,976,000 | 12,966,000 | 0.01% |
2023-09-12 | Farther Finance Advisors, LLC | new | - | 649 | 649 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | new | - | 830,104 | 830,104 | 0.19% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | 14,944 | 53,566 | 0.01% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 42.42 | 753,377 | 1,525,810 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.06 | 3,022,040 | 11,453,900 | 0.02% |
2023-08-21 | BOKF, NA | reduced | -2.54 | 803,906 | 3,089,600 | 0.06% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 44.59 | 3,131,220 | 6,246,700 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 445,000 | 1,595,000 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Inspire Medical Systems
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 10.31% | 2,978,391 | SC 13G/A | |
| Jan 31, 2023 | blackrock inc. | 7.4% | 2,135,708 | SC 13G/A | |
| Nov 10, 2022 | vanguard group inc | 10.04% | 2,899,902 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 6.7% | 1,846,227 | SC 13G/A | |
| Jan 10, 2022 | fmr llc | - | 0 | SC 13G/A | |
| Feb 12, 2021 | orbimed advisors llc | 0.00% | 0 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 8.92% | 2,401,971 | SC 13G | |
| Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A | |
| Feb 02, 2021 | blackrock inc. | 7.4% | 1,993,714 | SC 13G |
Recent SEC filings of Inspire Medical Systems
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 18, 2023 | 4 | Insider Trading | |
| Sep 13, 2023 | 4 | Insider Trading | |
| Aug 30, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 22, 2023 | 4 | Insider Trading | |
| Aug 11, 2023 | 4 | Insider Trading | |
| Aug 09, 2023 | 4 | Insider Trading | |
| Aug 08, 2023 | 4 | Insider Trading | |
| Aug 02, 2023 | 3 | Insider Trading |
Peers (Alternatives to Inspire Medical Systems)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 108.3B | 19.5B | 3.38% | 36.58% | 39.99 | 5.57 | 10.36% | 30.30% |
ISRG | 103.0B | 6.7B | -0.75% | 50.83% | 72.29 | 15.46 | 11.75% | -0.66% |
BSX | 77.8B | 13.4B | 6.45% | 36.39% | 85.31 | 5.81 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -4.29% | 12.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.2B | 5.7B | -8.22% | -17.24% | 30.39 | 7.46 | 5.64% | -4.53% |
| MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -2.12% | 37.22% | 325.65 | 10.11 | 16.30% | 250.21% |
INSP | 5.4B | 526.1M | -12.44% | 8.39% | -132.09 | 10.31 | 74.86% | 6.49% |
GMED | 5.1B | 1.1B | -6.10% | -12.07% | 24.23 | 4.65 | 12.63% | 50.85% |
IRTC | 2.6B | 452.1M | -21.20% | -33.94% | -26.32 | 5.78 | 24.99% | 24.09% |
OMCL | 2.3B | 1.2B | -12.37% | -42.27% | -97.15 | 1.82 | -1.77% | -138.27% |
| SMALL-CAP | ||||||||
SDGR | 2.1B | 193.8M | -23.50% | 16.21% | 31.34 | 10.73 | 18.78% | 144.88% |
AVNS | 947.4M | 780.7M | -7.75% | -9.65% | -26.32 | 1.21 | 4.68% | -510.17% |
ICAD | 47.7M | 24.5M | -18.18% | -19.57% | -3.81 | 1.95 | -24.11% | 3.57% |
HTGM | 1.3M | 6.2M | -81.65% | 3.23% | -0.06 | 0.21 | -28.21% | -7.22% |
Inspire Medical Systems News
Returns for INSP
Cumulative Returns on INSP
33.0%
5-Year Cumulative Returns
13.1%
3-Year Cumulative Returns
Risks for INSP
What is the probability of a big loss on INSP?
96.5%
Probability that Inspire Medical Systems stock will be more than 20% underwater in next one year
73.5%
Probability that Inspire Medical Systems stock will be more than 30% underwater in next one year.
29.6%
Probability that Inspire Medical Systems stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does INSP drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Inspire Medical Systems was unfortunately bought at previous high price.
Drawdowns
Financials for Inspire Medical Systems
Income Statement (Last 12 Months)
| Income Statement (Last 12 Months) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 12.8% | 526,077,000 | 466,371,000 | 407,856,000 | 348,354,000 | 300,851,000 | 262,424,000 | 233,394,000 | 201,005,000 | 175,162,000 | 134,386,000 | 115,381,000 | 96,278,000 | 81,298,000 | 87,147,000 | 82,050,000 | 71,703,000 | 63,895,000 | 56,801,000 | 50,593,000 | 43,991,000 | 38,208,000 |
| Gross Profit | 12.7% | 439,999,000 | 390,372,000 | 341,741,000 | 293,235,000 | 256,894,000 | 225,122,000 | 200,115,000 | 171,721,000 | 149,291,000 | 114,079,000 | 97,758,000 | 81,577,000 | 68,352,000 | 73,061,000 | 68,407,000 | 59,106,000 | 52,287,000 | 46,185,000 | 40,537,000 | 35,247,000 | 30,366,000 |
| Operating Expenses | 11.8% | 493,625,000 | 441,406,000 | 389,333,000 | 342,313,000 | 298,574,000 | 265,339,000 | 239,965,000 | 216,812,000 | 194,478,000 | 169,536,000 | 153,966,000 | 140,016,000 | 125,550,000 | 115,621,000 | 103,304,000 | 89,607,000 | 78,786,000 | 70,145,000 | 60,915,000 | 54,574,000 | 48,693,000 |
| S&GA Expenses | 10.0% | 395,044,000 | 359,112,000 | 320,688,000 | 284,622,000 | 252,262,000 | 224,273,000 | 202,615,000 | 182,471,000 | 162,444,000 | 140,728,000 | 127,874,000 | 117,442,000 | 106,660,000 | 99,947,000 | 90,465,000 | 78,383,000 | 69,414,000 | 61,884,000 | 53,527,000 | 50,208,000 | 44,058,000 |
| R&D Expenses | 19.8% | 98,581,000 | 82,294,000 | 68,645,000 | 57,691,000 | 46,312,000 | 41,066,000 | 37,350,000 | 34,341,000 | 32,034,000 | 28,808,000 | 26,092,000 | 22,574,000 | 18,890,000 | 15,674,000 | 12,839,000 | 11,224,000 | 9,372,000 | 8,261,000 | 7,388,000 | 6,918,000 | 6,323,000 |
| EBITDA | 100.0% | - | -39,640,000 | -40,733,000 | -46,066,000 | -40,105,000 | -38,939,000 | -38,642,000 | -43,932,000 | -43,990,000 | -54,121,000 | -54,171,000 | -55,758,000 | -53,811,000 | -38,475,000 | -30,584,000 | - | - | - | - | - | - |
| EBITDA Margin | 100.0% | - | -0.08 | -0.10 | -0.13 | -0.13 | -0.15 | -0.17 | -0.22 | -0.25 | -0.40 | -0.47 | -0.58 | -0.66 | -0.44 | -0.37 | - | - | - | - | - | - |
| Interest Expenses | -43.0% | 656,000 | 1,150,000 | 1,677,000 | 2,215,000 | 2,096,000 | 2,132,000 | 2,128,000 | 2,123,000 | 2,119,000 | 2,115,000 | 2,117,000 | 2,114,000 | 2,110,000 | 2,107,000 | 2,119,000 | 2,278,000 | 2,429,000 | 2,456,000 | 3,304,000 | 3,144,000 | 2,892,000 |
| Earnings Before Taxes | 6.1% | -40,272,000 | -42,882,000 | -44,268,000 | -49,914,000 | -43,657,000 | -42,371,000 | -41,970,000 | -47,055,000 | -47,009,000 | -57,036,000 | -57,088,000 | -58,672,000 | -56,621,000 | -41,182,000 | -33,203,000 | -28,941,000 | -25,387,000 | -23,593,000 | -21,828,000 | -21,301,000 | -20,631,000 |
| EBT Margin | 100.0% | - | -0.09 | -0.11 | -0.14 | -0.15 | -0.16 | -0.18 | -0.23 | -0.27 | -0.42 | -0.49 | -0.61 | -0.70 | -0.47 | -0.40 | - | - | - | - | - | - |
| Net Income | 5.8% | -41,073,000 | -43,611,000 | -44,881,000 | -50,422,000 | -43,922,000 | -42,520,000 | -42,042,000 | -47,135,000 | -47,173,000 | -57,174,000 | -57,203,000 | -58,799,000 | -56,661,000 | -41,222,000 | -33,243,000 | -28,941,000 | -25,387,000 | -23,593,000 | -21,828,000 | -21,302,000 | -20,631,000 |
| Net Income Margin | 100.0% | - | -0.09 | -0.11 | -0.14 | -0.15 | -0.16 | -0.18 | -0.23 | -0.27 | -0.43 | -0.50 | -0.61 | -0.70 | -0.47 | -0.41 | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 11,339,000 | 2,473,000 | -13,645,000 | -22,624,000 | -27,028,000 | -24,787,000 | -29,702,000 | -38,337,000 | -52,192,000 | -55,500,000 | -57,304,000 | -51,188,000 | -39,398,000 | -35,585,000 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 8.1% | 618 | 572 | 565 | 528 | 292 | 290 | 295 | 279 | 272 | 273 | 281 | 272 | 271 | 166 | 181 | 183 | 186 | 190 | 200 | 131 | 134 |
| Current Assets | 5.0% | 560 | 534 | 530 | 496 | 263 | 262 | 269 | 255 | 249 | 261 | 270 | 267 | 267 | 155 | 171 | 170 | 177 | 189 | 199 | 130 | 133 |
| Cash Equivalents | 5.6% | 467 | 442 | 442 | 418 | 187 | 203 | 214 | 210 | 177 | 182 | 191 | 179 | 211 | 76.00 | 23.00 | 48.00 | 51.00 | 102 | 97.00 | 26.00 | 122 |
| Inventory | 33.1% | 21.00 | 16.00 | 12.00 | 15.00 | 22.00 | 22.00 | 17.00 | 16.00 | 13.00 | 11.00 | 8.00 | 9.00 | 10.00 | 7.00 | 6.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 4.00 |
| Net PPE | 20.5% | 25.00 | 21.00 | 17.00 | 14.00 | 11.00 | 9.00 | 8.00 | 8.00 | 7.00 | 7.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Liabilities | 32.3% | 89.00 | 67.00 | 69.00 | 57.00 | 65.00 | 65.00 | 66.00 | 59.00 | 52.00 | 50.00 | 51.00 | 43.00 | 38.00 | 38.00 | 41.00 | 37.00 | 33.00 | 32.00 | 36.00 | - | - |
| Current Liabilities | 11.4% | 67.00 | 60.00 | 61.00 | 49.00 | 47.00 | 43.00 | 41.00 | 34.00 | 24.00 | 19.00 | 21.00 | 18.00 | 13.00 | 14.00 | 17.00 | 13.00 | 9.00 | 8.00 | 11.00 | 8.00 | 9.00 |
| Shareholder's Equity | 4.9% | 529 | 505 | 496 | 470 | 227 | 225 | 229 | 220 | 220 | 223 | 230 | 229 | 234 | 127 | 140 | 146 | 152 | 157 | 164 | 98.00 | 103 |
| Retained Earnings | -3.5% | -351 | -339 | -324 | -327 | -310 | -296 | -279 | -277 | -266 | -253 | -237 | -229 | -219 | -196 | -180 | -171 | -162 | -155 | -146 | -142 | -137 |
| Additional Paid-In Capital | 4.3% | 881 | 844 | 820 | 798 | 538 | 521 | 508 | 497 | 487 | 477 | 467 | 459 | 453 | 323 | 320 | 317 | 315 | 313 | 311 | 240 | 240 |
| Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Shares Outstanding | 0.6% | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 | 28.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 26.00 | 24.00 | 24.00 | 24.00 | 24.00 | 23.00 | 15.00 | 12.00 | 14.00 |
Cashflow (Last 12 Months)(In Thousands)
| Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 48.1% | 34,019 | 22,973 | 11,569 | -6,966 | -18,306 | -22,466 | -20,119 | -24,963 | -33,534 | -48,671 | -53,045 | -55,011 | -49,046 | -36,679 | -32,846 | -29,359 | -29,968 | -23,218 | -18,694 | -19,382 | -18,956 |
| Share Based Compensation | 14.7% | 69,382 | 60,474 | 51,970 | 43,999 | 36,220 | 29,902 | 26,178 | 23,002 | 19,503 | 16,065 | 12,817 | 10,856 | 9,069 | 7,555 | 6,197 | 4,827 | 3,675 | 2,555 | 1,219 | 750 | 459 |
| Cashflow From Investing | 74.5% | -5,570 | -21,884 | -19,596 | -17,179 | 16,732 | 28,995 | 29,139 | 41,068 | -15,010 | 18,065 | 86,627 | 55,239 | 80,667 | 7,726 | -43,559 | -19,945 | -111,478 | -67,858 | -83,389 | -89,459 | -2,351 |
| Cashflow From Financing | 6.0% | 251,979 | 237,664 | 235,077 | 231,864 | 11,582 | 14,442 | 14,948 | 15,393 | 13,862 | 136,828 | 134,065 | 130,441 | 128,321 | 3,117 | 1,964 | 70,977 | 70,831 | 181,832 | 190,383 | 120,613 | 120,653 |
INSP Income Statement
2023-06-30Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenue | $ 151,092 | $ 91,386 | $ 278,989 | $ 160,768 |
| Cost of goods sold | 24,252 | 14,173 | 44,140 | 24,177 |
| Gross profit | 126,840 | 77,213 | 234,849 | 136,591 |
| Operating expenses: | ||||
| Research and development | 30,821 | 14,534 | 56,340 | 26,404 |
| Selling, general and administrative | 112,618 | 76,686 | 214,606 | 140,250 |
| Total operating expenses | 143,439 | 91,220 | 270,946 | 166,654 |
| Operating loss | (16,599) | (14,007) | (36,097) | (30,063) |
| Other expense (income): | ||||
| Interest and dividend income | (4,922) | (297) | (9,195) | (331) |
| Interest expense | 0 | 494 | 0 | 1,021 |
| Other expense, net | 61 | 144 | 44 | 189 |
| Total other (income) expense | (4,861) | 341 | (9,151) | 879 |
| Loss before income taxes | (11,738) | (14,348) | (26,946) | (30,942) |
| Income taxes | 214 | 142 | 430 | 242 |
| Net loss | (11,952) | (14,490) | (27,376) | (31,184) |
| Other comprehensive loss: | ||||
| Foreign currency translation gain | 72 | 42 | 177 | 42 |
| Unrealized (loss) gain on investments | (1) | (45) | 12 | (188) |
| Total comprehensive loss | $ (11,881) | $ (14,493) | $ (27,187) | $ (31,330) |
| Net loss per share, basic (in dollars per share) | $ (0.41) | $ (0.53) | $ (0.94) | $ (1.13) |
| Net loss per share, diluted (in dollars per share) | $ (0.41) | $ (0.53) | $ (0.94) | $ (1.13) |
| Weighted average common shares used to compute net loss per share, basic (in shares) | 29,229,922 | 27,594,874 | 29,160,323 | 27,556,286 |
| Weighted average common shares used to compute net loss per share, diluted (in shares) | 29,229,922 | 27,594,874 | 29,160,323 | 27,556,286 |
INSP Balance Sheet
2023-06-30Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 467,051 | $ 441,592 |
| Investments, short-term | 0 | 9,821 |
| Accounts receivable, net of allowance for credit losses of $917 and $36, respectively | 63,500 | 61,228 |
| Inventories, net | 20,840 | 11,886 |
| Prepaid expenses and other current assets | 8,685 | 5,505 |
| Total current assets | 560,076 | 530,032 |
| Property and equipment, net | 25,217 | 17,249 |
| Operating lease right-of-use assets | 21,368 | 6,880 |
| Other non-current assets | 11,585 | 10,715 |
| Total assets | 618,246 | 564,876 |
| Current liabilities: | ||
| Accounts payable | 39,961 | 26,847 |
| Accrued expenses | 26,726 | 34,339 |
| Total current liabilities | 66,687 | 61,186 |
| Operating lease liabilities, non-current portion | 22,054 | 7,536 |
| Other non-current liabilities | 146 | 146 |
| Total liabilities | 88,887 | 68,868 |
| Stockholders' equity: | ||
| Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
| Common Stock, $0.001 par value per share; 200,000,000 shares authorized; 29,326,179 and 29,008,368 issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 29 | 29 |
| Additional paid-in capital | 880,873 | 820,335 |
| Accumulated other comprehensive income (loss) | 103 | (86) |
| Accumulated deficit | (351,646) | (324,270) |
| Total stockholders' equity | 529,359 | 496,008 |
| Total liabilities and stockholders' equity | $ 618,246 | $ 564,876 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.